Spinocerebellar ataxia type 2: Measures of saccade changes improve power for clinical trials.
about
Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches.Heritability of saccadic eye movements in spinocerebellar ataxia type 2: insights into an endophenotype marker.The progression rate of spinocerebellar ataxia type 2 changes with stage of disease.Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2.Neuroimmunology Research. A Report from the Cuban Network of Neuroimmunology.Voxel-based meta-analysis of gray and white matter volume abnormalities in spinocerebellar ataxia type 2
P2860
Spinocerebellar ataxia type 2: Measures of saccade changes improve power for clinical trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Spinocerebellar ataxia type 2: ...... ove power for clinical trials.
@en
Spinocerebellar ataxia type 2: ...... ove power for clinical trials.
@nl
type
label
Spinocerebellar ataxia type 2: ...... ove power for clinical trials.
@en
Spinocerebellar ataxia type 2: ...... ove power for clinical trials.
@nl
prefLabel
Spinocerebellar ataxia type 2: ...... ove power for clinical trials.
@en
Spinocerebellar ataxia type 2: ...... ove power for clinical trials.
@nl
P2093
P2860
P356
P1433
P1476
Spinocerebellar ataxia type 2: ...... ove power for clinical trials.
@en
P2093
Georg Auburger
Jacqueline Medrano-Montero
Luis Velázquez-Pérez
Nalia Canales-Ochoa
Roberto Rodríguez-Labrada
Yaimeé Vázquez-Mojena
Yanetza González-Zaldivar
P2860
P304
P356
10.1002/MDS.26532
P407
P50
P577
2016-02-05T00:00:00Z